These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37880873)

  • 1. Trends and Outcomes of Type 2 Myocardial Infarction During the COVID-19 Pandemic in the United States.
    Thyagaturu H; Roma N; Angirekula A; Thangjui S; Bolton A; Gonuguntla K; Sattar Y; Chobufo MD; Challa A; Patel N; Bondi G; Raina S
    Korean Circ J; 2023 Dec; 53(12):829-839. PubMed ID: 37880873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends and Outcomes of Acute Myocardial Infarction During the Early COVID-19 Pandemic in the United States: A National Inpatient Sample Study.
    Thyagaturu H; Sandhyavenu H; Titus A; Roma N; Gonuguntla K; Navinkumar Patel N; Hashem A; Dawn Abbott J; Balla S; Bhatt DL
    Korean Circ J; 2024 Nov; 54(11):710-723. PubMed ID: 39175340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular outcomes of type 2 myocardial infarction among COVID-19 patients: a propensity matched national study.
    Sattar Y; Taha A; Patel N; Victor V; Titus A; Aziz S; Gonuguntla K; Thyagaturu H; Atti L; Micho T; Almas T; Tarun T; Alraies MC; Balla S
    Expert Rev Cardiovasc Ther; 2023 May; 21(5):365-371. PubMed ID: 37038300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of depression on in-hospital outcomes for adults with type 2 myocardial infarction: A United States population-based analysis.
    Neppala S; Chigurupati HD; Chauhan S; Chinthapalli MT; Desai R
    World J Cardiol; 2024 Jul; 16(7):412-421. PubMed ID: 39086894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial Disparities in Clinical Outcomes and Resource Utilization of Type 2 Myocardial Infarction in the United States: Insights From the National Inpatient Sample Database.
    Mhanna M; Minhas AMK; Ariss RW; Nazir S; Khan SU; Vaduganathan M; Blankstein R; Alam M; Nasir K; Virani SS
    Curr Probl Cardiol; 2023 Aug; 48(8):101202. PubMed ID: 35398361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Characteristics, Outcomes, and Epidemiological Trends of Patients Admitted With Type 2 Myocardial Infarction.
    Rogers E; Torres C; Rao SV; Donatelle M; Beohar N
    J Soc Cardiovasc Angiogr Interv; 2022; 1(5):100395. PubMed ID: 39131460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex-based differences in clinical outcomes and resource utilization of type 2 myocardial infarction.
    Ariss RW; Elzanaty AM; Minhas AMK; Nazir S; Gul S; Patel N; Ahuja KR; Mochon A; Eltahawy EA
    Int J Cardiol; 2021 Sep; 338():24-29. PubMed ID: 34058288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification Algorithm to Distinguish Between Type 1 and Type 2 Myocardial Infarction in Administrative Claims Data.
    Wasfy JH; Price M; Normand ST; Januzzi JL; McCarthy CP; Hsu J
    Circ Cardiovasc Qual Outcomes; 2024 Feb; 17(2):e009986. PubMed ID: 38240159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, Predictors, and Outcomes of Type 2 NSTEMI in Hospitalized Patients With COVID-19.
    Patel S; Visotcky A; Devine A; Kode V; Kotlo S; Aljadah M; Sparapani R; Kulinski J
    J Am Heart Assoc; 2024 May; 13(10):e032572. PubMed ID: 38726904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A National Perspective on the Impact of the COVID-19 Pandemic on Heart Failure Hospitalizations in the United States.
    Mishra T; Patel DA; Awadelkarim A; Sharma A; Patel N; Yadav N; Almas T; Sattar Y; Alraies MC
    Curr Probl Cardiol; 2023 Sep; 48(9):101749. PubMed ID: 37087079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rising Cardiovascular Mortality Despite Increased Resource Utilization: Insights From the Nationwide Inpatient Sample Database.
    Nebuwa C; Omoike OJ; Fagbenro A; Uwumiro F; Erhus E; Okpujie V; Fadeyibi I; Adike O; Osadolor AO
    Cureus; 2024 Apr; 16(4):e57856. PubMed ID: 38721189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic Sclerosis Is Associated With Increased Inpatient Mortality in Patients Admitted for Acute Coronary Syndrome: Analysis of the National Inpatient Sample.
    Edigin E; Ojemolon PE; Eseaton PO; Jamal S; Shaka H; Akuna E; Asemota IR; Manadan A
    J Clin Rheumatol; 2022 Jan; 28(1):e110-e117. PubMed ID: 33264253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disparities by sex, race, and region in acute myocardial infarction-related outcomes during the early COVID-19 pandemic: the national inpatient sample analysis.
    Thyagaturu H; Taha A; Ali S; Roma N; Duhan S; Patel N; Sattar Y; Gonuguntla K; Sandhyavenu H; Badu I; Michos ED; Balla S
    Am J Cardiovasc Dis; 2024; 14(3):153-171. PubMed ID: 39021522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case Rates, Treatment Approaches, and Outcomes in Acute Myocardial Infarction During the Coronavirus Disease 2019 Pandemic.
    Gluckman TJ; Wilson MA; Chiu ST; Penny BW; Chepuri VB; Waggoner JW; Spinelli KJ
    JAMA Cardiol; 2020 Dec; 5(12):1419-1424. PubMed ID: 32766756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT-2): A randomized trial design.
    Lambrakis K; French JK; Scott IA; Briffa T; Brieger D; Farkouh ME; White H; Chuang AM; Tiver K; Quinn S; Kaambwa B; Horsfall M; Morton E; Chew DP
    Am Heart J; 2019 Feb; 208():11-20. PubMed ID: 30522086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of Type 2 Myocardial Infarction and Readmission With Type 1 Myocardial Infarction in Hypertensive Crises (from a Nationwide Analysis).
    Maraey A; Elzanaty AM; Salem M; Khalil M; Elsharnoby H; Younes A; Elsharnouby M; Nazir S; Elgendy IY; Siragy HM
    Am J Cardiol; 2021 Dec; 161():56-62. PubMed ID: 34794619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six-month cardiovascular prognostic impact of type 1 And type 2 myocardial infarction in patients hospitalized for gastrointestinal bleeding.
    Pemmasani G; Ashwath A; Aronow WS; Yandrapalli S; Leighton J; John S
    Eur J Intern Med; 2023 Oct; 116():51-57. PubMed ID: 37500309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of COVID-19 on liver transplant recipients: A nationwide cohort study evaluating hospitalization, transplant rejection, and inpatient mortality.
    Inayat F; Patel P; Ali H; Afzal A; Tahir H; Chaudhry A; Ishtiaq R; Rehman AU; Darji K; Afzal MS; Nawaz G; Giammarino A; Satapathy SK
    World J Transplant; 2024 Jun; 14(2):90866. PubMed ID: 38947960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of objective evidence of myocardial ischemia to facilitate the diagnostic and prognostic distinction between type 2 myocardial infarction and myocardial injury.
    Sandoval Y; Smith SW; Sexter A; Schulz K; Apple FS
    Eur Heart J Acute Cardiovasc Care; 2020 Feb; 9(1):62-69. PubMed ID: 29979092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incident Type 2 Myocardial Infarction in a Cohort of Patients Undergoing Coronary or Peripheral Arterial Angiography.
    Gaggin HK; Liu Y; Lyass A; van Kimmenade RR; Motiwala SR; Kelly NP; Mallick A; Gandhi PU; Ibrahim NE; Simon ML; Bhardwaj A; Belcher AM; Harisiades JE; Massaro JM; D'Agostino RB; Januzzi JL
    Circulation; 2017 Jan; 135(2):116-127. PubMed ID: 27881568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.